Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2008 07:50 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Initiates Phase II Clinical Program in Rheumatoid Arthritis

CHARLOTTE, N.C., Jan. 23, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has initiated enrollment and patient dosing in a multinational, 12-week,...
January 07, 2008 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Initiates Phase II Study of Droxidopa in Intradialytic Hypotension

CHARLOTTE, N.C., Jan. 7, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that last month it initiated a Phase II trial of Droxidopa, an orally active...
November 13, 2007 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Third Quarter 2007 Results

CHARLOTTE, N.C., Nov. 13, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported financial results for the quarter and nine months ended September 30, 2007, presented...
November 12, 2007 08:00 ET | Source: Chelsea Therapeutics

FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa

CHARLOTTE, N.C., Nov. 12, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational...
November 08, 2007 16:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Completes $48.9 Million in Registered Direct Offering

CHARLOTTE, N.C., Nov. 8, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has completed its previously announced registered direct offering of...
November 07, 2007 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2007 Results On November 13, 2007

CHARLOTTE, N.C., Nov. 7, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will report its unaudited financial results for the third quarter ended...
November 02, 2007 09:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Raise $48.9 Million in Registered Direct Offering

CHARLOTTE, N.C., Nov. 2, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has entered into definitive securities purchase agreements with several...
September 24, 2007 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Announces Phase III Protocols for Droxidopa

CHARLOTTE, N.C., Sept. 24, 2007 (PRIME NEWSWIRE) -- Following a successful meeting with the FDA, Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced its planned clinical protocol for its...
September 12, 2007 07:55 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present At the ThinkEquity Partners 5th Annual Growth Conference

CHARLOTTE, N.C., Sept. 12, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the ThinkEquity Partners 5th Annual Growth Conference at 11:00 AM...
September 10, 2007 07:55 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Resolves Bioavailability Issue and Reports Greater Than 10-Fold Improvement in Relative Bioavailability of New CH-1504 Formulation

CHARLOTTE, N.C., Sept. 10, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported results from its human bioequivalence study quantifying the improvements in relative...